0001855763-22-000001.txt : 20220308 0001855763-22-000001.hdr.sgml : 20220308 20220308171841 ACCESSION NUMBER: 0001855763-22-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220308 FILED AS OF DATE: 20220308 DATE AS OF CHANGE: 20220308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baxter Nicholas W CENTRAL INDEX KEY: 0001312326 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39874 FILM NUMBER: 22722789 MAIL ADDRESS: STREET 1: 220 SPRINGFIELD ROAD STREET 2: ABERDEEN CITY: ABERDEENSHIRE, SCOTLAND STATE: X0 ZIP: AB15 6AU ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 BUSINESS ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 BUSINESS PHONE: 250-765-6424 MAIL ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2022-03-08 0 0001348362 Lexaria Bioscience Corp. LEXX 0001312326 Baxter Nicholas W 37H KING'S GATE ABERDEEN ABERDEEN X0 AB15 4EL UNITED KINGDOM 1 0 0 0 common shares 11000 D Stock Options 5.31 2021-04-26 2026-04-26 Common Shares 1500 1500 D Stock Options 7.08 2021-06-08 2026-06-08 Common Shares 5000 6500 D Stock Options 6.23 2021-09-01 2026-09-01 Common Shares 1900 8400 D Stock Options 3.39 2022-03-08 4 A 0 3400 0 A 2022-03-08 2027-03-08 Common Shares 3400 11800 D /Nicholas Baxter/ 2022-03-08